Facilitating Innovative Nuclear Diagnostics Act of 2021

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS)

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS)

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS)

Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609

Client expense: $410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Health Care Trade and Supply Chain Security. Issues related to AI in Health Care. Issues related to Department of Health and Human Services Appropriations. Issues related to research and development tax policy. HR 1846, To amend the Public Health Service Act with respect to hospital infrastructure, all provisions. HR 4479 / S 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021, all provisions. S 2107, Facilitating American-Built Semiconductors Act, all provisions. HR 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022, all provisions. HR 5585, Advanced Research Projects Agency - Health Act, all provisions. S 3983 / HR 7084, PATCH Act of 2022, all provisions. HR 7667, Food and Drug Amendments of 2022, all provisions. HR 4521 / S 1260, United States Innovation and Competition Act of 2021, all provisions. S 2533 / HR 4794, Making Advances in Mammography and Medical Options for Veterans Act, all provisions. S 2102, Dr. Kate Hendricks Thomas SERVICE Act, all provisions. HR 4571, Supporting Expanded Review for Veterans In Combat Environments Act of 2021, all provisions. HR 2617, Consolidated Appropriations Act, 2023, provisions pertaining to health care cyber security, medical contrast and diagnostic radiopharmaceutical regulation, and HHS ASPR Hospital Preparedness Program appropriations. S 3799, PREVENT Pandemics Act, provisions pertaining medical device shortage reporting.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advocated in the House, Senate and CMS for passage of the Facilitating Innovative Nuclear Diagnostics (FIND) Act (HR 4479/S 2609). Encouraged the Centers for Medicare and Medicaid to fully open its reconsideration and remove the national non-coverage for amyloid PET diagnostics.

Client expense: $430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Proposed Part B IPI Demonstration Project; Drug Pricing; CMS NCD for Alzheimer's Drugs; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.4479/S.2609, Facilitating Innovative Nuclear Diagnostics Act of 2021; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to medical device cybersecurity, including S.3983/H.R. 7084, PATCH Act, Artificial Intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the thirty-party servicing of medical devices and remanufacturing of medical devices, including H.R. 7253, the Clarifying Remanufacturing to Protect Patient Safety Act of 2022. Issues related to S.2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Expanding dental health coverage in Medicare by clarifying CMS's interpretation of the statutory dental exclusion. Expanding access to health care for people living with Parkinson's via telehealth by removing Medicare telehealth geographic and originating site restrictions, extending coverage and reimbursement for health care providers who bill Medicare for providing services via telehealth (including seeing new patients and audio-only telehealth for clinically appropriate services/visits), ensuring payment parity for telehealth and in-person services, and removing Medicare in-person requirements for accessing mental health services via telehealth. H.R. 2617, Consolidated Appropriations Act, 2023; S. 2061/H.R. 4058, Telemental Health Care Access Act of 2021; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies Increasing drug affordability and accessibility for people living with Parkinsons via drug pricing, Medicare Part D redesign and benefits, capping out-of-pocket costs and smoothing, and streamlining prior authorization processes. H.R. 5375, Inflation Reduction Act of 2022; H.R. 4417, Capping Drug Costs for Seniors Act; S. 4011, Capping Drug Costs for Seniors Act of 2022 Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 H.R. 3733: Essential Caregivers Act of 2021

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General education around pharmaceuticals related to Parkinson's disease. Increasing drug affordability and accessibility for people living with Parkinsons via drug pricing, Medicare Part D redesign and benefits, capping out-of-pocket costs and smoothing, and streamlining prior authorization processes. H.R. 5375, Inflation Reduction Act of 2022; H.R. 4417, Capping Drug Costs for Seniors Act; S. 4011, Capping Drug Costs for Seniors Act of 2022. S. 464/H.R. 2163, the Safe Step Act - to amend the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol to enable people living with Parkinsons disease to access the medications they need to best manage their disease Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities. H.R. 8585/S. 4851, the National Plan to End Parkinson's Act - to require the U.S. Department of Health and Human Services (HHS) to carry out a project to prevent and cure Parkinson's disease. Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent and cure the disease; (2) improve diagnosis, treatment, and care of those with the disease; and (3) address health and other disparities related to the disease. HHS must also conduct annual assessments on the preparation for and response to the increased burden of Parkinson's disease. In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and cure of Parkinson's disease. Establishing Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and to allow researchers to gather more data to study the progression of Parkinson's among people living with the disease. Expanding access to health care for people living with Parkinson's via telehealth by removing Medicare telehealth geographic and originating site restrictions, extending coverage and reimbursement for health care providers who bill Medicare for providing services via telehealth (including seeing new patients and audio-only telehealth for clinically appropriate services/visits), ensuring payment parity for telehealth and in-person services, and removing Medicare in-person requirements for accessing mental health services via telehealth. H.R. 2617, the Consolidated Appropriations Act, 2023 Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 S. 464/H.R. 2163, the Safe Step Act - to amend the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol to enable people living with Parkinsons disease to access the medications they need to best manage their disease S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN (Bringing Regulatory Advances Into Neuroscience) Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT (Diverse and Equitable Participation in Clinical Trials) Act S. 331, ABLE (Achieving a Better Life Experience) Age Adjustment Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

H.R.4479 and S.2609 - Facilitating Innovative Nuclear Diagnostics (FIND) Act Medicare Hospital Outpatient Prospective Payment System policy packaging for diagnostic radiopharmaceuticals

Client expense: $75,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2617 - Consolidated Appropriations Act for Fiscal Year 2023 - Issues related to health care preparedness and information sharing to support real time health care decision making across the country. H.R. 5305 - Extending Government Funding and Delivering Emergency Assistance Act. Issues related to FDA User Fee Agreements. H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices. S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices. H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals. PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19. Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4479 and S.2609: Facilitating Innovative Nuclear Diagnostics Act (FIND Act); HR 4006: the Fair Repair Act; HR 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4479 and S.2609: Facilitating Innovative Nuclear Diagnostics Act (FIND Act); HR 4006: the Fair Repair Act; HR 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices.

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare beneficiary access to diagnostic radiopharmaceutical testing; Facilitating Innovative Nuclear Diagnostics Act of 2021 (H.R.4479, S.2609); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Meetings with House and Senate members/staff including House Ways and Means, Energy and Commerce and Senate Finance Committee staff regarding the Facilitating Innovative Nuclear Diagnostics Act (S 2609/HR 4479). Internal legislative strategy meetings; FIND Act Coalition legislative strategy meetings; physician and patient outreach; LTE campaign. Strategy, advocacy, and outreach activities with regard to CMS request for comment on Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) partial retirement of amyloid PET NCD. Strategy, advocacy, and outreach activities with regard to CMS request for comment on AHRQ's proposal seeking comments on Topic Refinement Regarding Draft Analysis of Requirements for Coverage with Evidence Development.

Client expense: $460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to Health Care Trade and Supply Chain Security. Issues related to AI in Health Care. Issues related to Department of Health and Human Services Appropriations. Issues related to research and development tax policy. HR 1846, To amend the Public Health Service Act with respect to hospital infrastructure, all provisions. HR 4479 / S 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021, all provisions. S 2107, Facilitating American-Built Semiconductors Act, all provisions. HR 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022, all provisions. HR 5585, Advanced Research Projects Agency - Health Act, all provisions. S 3983 / HR 7084, PATCH Act of 2022, all provisions. HR 7667, Food and Drug Amendments of 2022, all provisions. HR 4521 / S 1260, United States Innovation and Competition Act of 2021, all provisions. S 2533 / HR 4794, Making Advances in Mammography and Medical Options for Veterans Act, all provisions. S 2102, Dr. Kate Hendricks Thomas SERVICE Act, all provisions. HR 4571, Supporting Expanded Review for Veterans In Combat Environments Act of 2021, all provisions.

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; CMS NCD for Alzheimer's Drugs. H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376). H.R.4479/S.2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES

Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES

Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.4479 and S.2609 - Facilitating Innovative Nuclear Diagnostics (FIND) Act Medicare Hospital Outpatient Prospective Payment System policy packaging for diagnostic radiopharmaceuticals

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Expanding Medicare benefits to include dental, hearing, and vision Extending and making permanent COVID-19 telehealth flexibilities Increasing drug affordability and accessibility via drug pricing, Medicare Part D redesign and benefits, capping out-of-pocket costs and smoothing, and streamlining prior authorization processes Advocating for improvements to Medicare Part C and Part D proposed rule Inflation Reduction Act of 2022 H.R. 4417, the Capping Drug Costs for Seniors Act S. 2327, the Seniors Prescription Drug Relief Act S. 828/H.R. 432, the Mental Health Access Improvement Act of 2021 H.R. 2080, the Seniors Access to Vaccine Ensured Act of 2021 H.R. 3173/S. 3018, the Improving Seniors Timely Access to Care Act H.R. 4011, the Capping Drug Costs for Seniors Act of 2022 H.R. 4479/S. 2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 S. 2061/H.R. 4058, the Telemental Health Care Access Act of 2021 S. 1512/H.R. 2903, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021 H.R. 1332/S. 368, the Telehealth Modernization Act H.R. 366, the Protecting Access to Post-COVID-19 Telehealth Act of 2021 H.R. 3733: Essential Caregivers Act of 2021 H.R. 6202, the Telehealth Extension Act of 2021 S. 3575, the Stop the Wait Act of 2022 S. 3593, the Telehealth Extension and Evaluation Act S. 3675, the Beneficiary Enrollment Notification and Eligibility Simplification (BENES) 2.0 Act H.R. 7051/S. 3791, the Access to Prescription Digital Therapeutics Act of 2022 H.R. 5375, the Inflation Reduction Act of 2022

Client expense: $31,190 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General education around pharmaceuticals related to Parkinson's disease Increasing drug affordability and accessibility via drug pricing, Medicare Part D redesign and benefits, and streamlining prior authorization processes and step therapy protocols Prescription Drug User Fee Act H.R. 4417, the Capping Drug Costs for Seniors Act H.R. 4479/S. 2609, the Facilitating Innovative Nuclear Diagnostics Act of 2021 S. 2327, the Seniors Prescription Drug Relief Act H.R. 3173/S. 3018, the Improving Seniors Timely Access to Care Act of 2021 H.R. 2163, the Safe Step Act H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act H.R. 5376, the Inflation Reduction Act of 2022

Client expense: $31,190 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5305 - Extending Government Funding and Delivering Emergency Assistance Act. Issues related to FDA User Fee Agreements. H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices. S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices. H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals. PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19. Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); H.R. 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices; H.R. 4006: the Fair Repair Act; Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).

Client expense: $390,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Health Care Trade and Supply Chain Security. Issues related to AI in Health Care. Issues related to Department of Health and Human Services Appropriations. Issues related to research and development tax policy. HR 1846, To amend the Public Health Service Act with respect to hospital infrastructure, all provisions. HR 4479 / S 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021, all provisions. S 2107, Facilitating American-Built Semiconductors Act, all provisions. HR 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022, all provisions. HR 5585, Advanced Research Projects Agency - Health Act, all provisions. S 3983 / HR 7084, PATCH Act of 2022, all provisions. HR 7667, Food and Drug Amendments of 2022, all provisions. HR 4521 / S 1260, United States Innovation and Competition Act of 2021, all provisions. S 2533 / HR 4794, Making Advances in Mammography and Medical Options for Veterans Act, all provisions. S 2102, Dr. Kate Hendricks Thomas SERVICE Act, all provisions. HR 4571, Supporting Expanded Review for Veterans In Combat Environments Act of 2021, all provisions.

Client expense: $850,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 4479 and S.2609: Facilitating Innovative Nuclear Diagnostics Act (FIND Act); HR 4006: the Fair Repair Act; HR 6566: the Freedom to Repair Act regarding right to repair and exempting medical devices.

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare beneficiary access to diagnostic radiopharmaceutical testing; Facilitating Innovative Nuclear Diagnostics Act of 2021 (H.R.4479/S.2609); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office